AR
Arthur F Ryan
Director

Arthur F Ryan insider trades: Regeneron Pharmaceuticals (REGN) stock buys and sales

Director, Regeneron Pharmaceuticals Last trade Jul 2, 2026 102 Form 4 filings
$286K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
65
Open-market trades
since 2010
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Arthur reports to the SEC

Open-market buys and sales

65 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 2, 2026REGN↓ Sell$130K
Apr 1, 2026REGN↓ Sell$78K
Mar 2, 2026REGN↓ Sell$79K
Oct 1, 2024REGN↓ Sell$105K
Sep 3, 2024REGN↓ Sell$118K
Aug 1, 2024REGN↓ Sell$107K
Aug 1, 2024REGN↓ Sell$1K
Jul 1, 2024REGN↓ Sell$106K
Jun 3, 2024REGN↓ Sell$99K
May 1, 2024REGN↓ Sell$90K
Apr 1, 2024REGN↓ Sell$96K
Mar 1, 2024REGN↓ Sell$98K
Feb 1, 2024REGN↓ Sell$95K
Jan 2, 2024REGN↓ Sell$90K
Dec 1, 2023REGN↓ Sell$82K
Nov 7, 2023REGN↓ Sell$83K
Aug 1, 2023REGN↓ Sell$74K
Jul 3, 2023REGN↓ Sell$72K
Jun 1, 2023REGN↓ Sell$74K
May 1, 2023REGN↓ Sell$81K
Apr 3, 2023REGN↓ Sell$82K
Mar 1, 2023REGN↓ Sell$76K
Feb 1, 2023REGN↓ Sell$76K
Jan 3, 2023REGN↓ Sell$73K
Dec 1, 2022REGN↓ Sell$76K
Nov 1, 2022REGN↓ Sell$76K
Oct 3, 2022REGN↓ Sell$73K
Sep 6, 2022REGN↓ Sell$58K
Aug 4, 2022REGN↓ Sell$6.5M
May 2, 2022REGN↓ Sell$65K
Apr 1, 2022REGN↓ Sell$69K
Mar 1, 2022REGN↓ Sell$62K
Feb 1, 2022REGN↓ Sell$61K
Jan 3, 2022REGN↓ Sell$62K
Dec 1, 2021REGN↓ Sell$64K
Nov 1, 2021REGN↓ Sell$64K
Oct 1, 2021REGN↓ Sell$57K
Sep 1, 2021REGN↓ Sell$68K
Aug 2, 2021REGN↓ Sell$58K
Jul 1, 2021REGN↓ Sell$56K
Jun 14, 2021REGN↓ Sell$52K
Feb 1, 2021REGN↓ Sell$51K
Jan 4, 2021REGN↓ Sell$48K
Dec 1, 2020REGN↓ Sell$52K
Nov 2, 2020REGN↓ Sell$55K
Oct 1, 2020REGN↓ Sell$56K
Sep 1, 2020REGN↓ Sell$60K
Aug 3, 2020REGN↓ Sell$64K
Jul 1, 2020REGN↓ Sell$61K
Jun 1, 2020REGN↓ Sell$60K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other REGN insiders

Open-market trades in the last 12 months

About Arthur F Ryan's insider trades

Arthur F Ryan is a director at Regeneron Pharmaceuticals (REGN). Since Jun 14, 2010, Arthur has reported 3 open-market purchases worth $1.2M and 62 sales worth $59.5M on SEC Form 4. In the last 12 months: 3 sales ($286K).

Their filings also include grants and awards (41 filings), gifts (10 filings), option exercises (5 filings), shares withheld for taxes (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every REGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.